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The bacterial pathogen Listeria monocytogenes causes food-borne illnesses culminating in gastroenteritis,
meningitis, or abortion. Listeria induces its internalization into some mammalian cells through binding of the
bacterial surface protein InlB to the host receptor tyrosine kinase Met. Interaction of InlB with the Met
receptor elicits host downstream signaling pathways that promote F-actin cytoskeletal changes responsible for
pathogen engulfment. Here we show that the mammalian signaling protein ARAP2 plays a critical role in
cytoskeletal remodeling and internalization of Listeria. Depletion of ARAP2 through RNA interference (RNAi)
caused a marked inhibition of InlB-mediated F-actin rearrangements and bacterial entry. ARAP2 contains
multiple functional domains, including a GTPase-activating protein (GAP) domain that antagonizes the
GTPase Arf6 and a domain capable of binding the GTPase RhoA. Genetic data indicated roles for both the Arf
GAP and RhoA binding domains in Listeria entry. Experiments involving Arf6 RNAi or a constitutively
activated allele of Arf6 demonstrated that one of the ways in which ARAP2 promotes bacterial uptake is by
restraining the activity of Arf6. Conversely, Rho activity was dispensable for Listeria internalization, suggesting
that the RhoA binding domain in ARAP2 acts by engaging a host ligand other than Rho proteins. Collectively,
our findings indicate that ARAP2 promotes InlB-mediated entry of Listeria, in part, by antagonizing the host
GTPase Arf6.
Listeria monocytogenes is a Gram-positive, food-borne bac-
terial pathogen capable of causing gastroenteritis, meningitis,
or abortions (39, 32). Listeria induces its own internalization
(entry) into nonphagocytic mammalian cells, a process that
likely plays an important role in traversal of the intestinal,
placental, and blood-brain barriers (7, 14, 16, 23). One of the
pathways of Listeria entry is mediated by interaction of the
bacterial surface protein InlB with its host receptor, the Met
receptor tyrosine kinase (16, 37).
InlB-Met interaction triggers activation (tyrosine phosphor-
ylation) of the Met receptor and subsequent rearrangements in
the F-actin cytoskeleton of the mammalian cell (16, 29). These
cytoskeletal changes remodel the host cell surface, resulting in
engulfment of adherent Listeria. One of the host mammalian
proteins that acts downstream of Met to promote F-actin re-
arrangements and bacterial entry is type IA phosphoinositide
(PI) 3-kinase (8, 17, 18). This PI 3-kinase is a heterodimeric
enzyme comprised of an 85-kDa regulatory subunit and a 110-
kDa catalytic subunit (4, 11). p85-p110 generates phosphati-
dylinositol 4,5-bisphosphate [PI(4,5)P2)] and phosphatidylino-
sitol 3,4,5-trisphosphate [PI(3,4,5)P3], which are lipid second
messengers that regulate a variety of biological processes, in-
cluding growth, survival, and motility of mammalian cells. A
plethora of downstream “target” proteins that bind PI(4,5)P2
and/or PI(3,4,5)P3 and mediate the biological effects of p85-
p110 have been identified (4, 24). However, mammalian pro-
teins that act downstream of type IA PI 3-kinase to control
Listeria uptake have yet to found.
In this work, we demonstrate that the human GTPase-acti-
vating protein (GAP) ARAP2 is required for InlB-mediated
cytoskeletal changes and entry of Listeria. ARAP2 is known to
bind PI(3,4,5)P3, resulting in upregulation of a GAP domain
that inactivates the mammalian GTPase Arf6 (42). We pro-
vide genetic evidence indicating that the ArfGAP domain of
ARAP2 stimulates Listeria entry by antagonizing Arf6. ARAP2
has several functional domains in addition to its ArfGAP do-
main. One of these domains in ARAP2 interacts with the
mammalian GTPase RhoA (42). Our genetic data demon-
strate that this “RhoA binding” (RB) domain also plays a
critical role in bacterial entry. Surprisingly, pharmacological
experiments indicate that the RB domain controls Listeria up-
take through an unknown mechanism that does not involve
Rho proteins. Our work indicates a key role for host ARAP2
in InlB-mediated entry of Listeria. One of the likely ways that
type IA PI 3-kinase controls entry of Listeria is through regu-
lation of ARAP2.
MATERIALS AND METHODS
Bacterial strains, mammalian cell lines, and media. The wild-type Listeria
monocytogenes strain EGD and the isogenic inlB mutant strain containing an
in-frame deletion of the inlB gene were previously described (10). These strains
were grown in brain heart infusion (BHI) broth (Difco) and prepared for infec-
tion as described previously (10, 18).
The human epithelial cell line HeLa (ATTC CCL-2) was grown in Dulbecco’s
modified Eagle’s medium (DMEM) with 4.5 g of glucose per liter and 2 mM
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glutamine (11995-065; Invitrogen), supplemented with 10% fetal bovine serum
(FBS). Cell growth, cell stimulation, and bacterial infections were performed at
37°C with 5% CO2.
Antibodies, inhibitors, siRNAs, and other reagents. The polyclonal antibodies
used were anti-ARAP2 1185 (42), anti-Met C-12 (sc-10; Santa Cruz Biotechnol-
ogy), rabbit anti-L. monocytogenes R11 (13), and polyclonal anti-InlB antiserum
(8). The monoclonal antibodies used were antitubulin (T5168; Sigma), anti-Flag
M2 (F3165), anti-Arf6 clone 3A1 (Santa Cruz Biotechnology, sc-7971), and
anti-green fluorescent protein (anti-GFP) clone B-2 (sc-9996; Santa Cruz Bio-
technology). Secondary antibody horseradish peroxidase (HRPO) or Cy5 con-
jugates were from Jackson Immunolabs. Secondary antibody or phalloidin con-
jugates coupled to Texas Red or BODYP FL were from Molecular Probes.
Recombinant hepatocyte growth factor (HGF) (294-HGN) was purchased from
R&D Systems. The PI 3-kinase inhibitor LY294002 (LL9908) was from Sigma,
and the cell-permeative C3 toxin (CT04) was from Cytoskeleton. Recombinant
InlB protein was expressed in Escherichia coli and purified essentially as de-
scribed previously (18). The negative, “nontargeting” control small interfering
RNA (siRNA) molecule 1 (catalog no. D-001210-01) was purchased from Dhar-
macon. This siRNA contains two or more mismatches with all sequences in the
human genome, indicating that it should not target host mRNAs. Compared with
cells treated with transfection reagent alone, control siRNA 1 did not affect entry
of the wild-type Listeria strain EGD into HeLa cells (see Fig. 1B, panel i). siRNA
molecules targeting mRNA encoding Arf6 (5-GCACCGCAUUAUCAAUGA
CCGUU-3) or ARAP2 (ARAP2-1, (5-GUAAGAAGACAUUGGGUUAUU-
3; ARAP2-2, 5-GGCUGGUUUGCUAUGGACAUU-3) were also from
Dharmacon. ARAP2-1 siRNA targets a sequence in the 3 untranslated region
(UTR) of ARAP2 mRNA (42), whereas ARAP2-2 siRNA is complementary to
a sequence in the coding region of the mRNA.
Plasmids. Mammalian expression plasmids encoding Flag-tagged wild-type,
R728K, and K1190P alleles of ARAP2 were previously described (42). These
plasmids were based on the expression vector pCI (42) and were kindly provided
by Paul Randazzo and Hye-Young Yoon (NIH, Bethesda, MD). As a control
plasmid for experiments for Fig. 2B, pCI harboring Flag-tagged firefly luciferase
was constructed using standard PCR-based techniques. The final sequence of the
Flag-luciferase insert was verified by DNA sequencing.
Transfection of mammalian cells with siRNA or plasmid DNA. Seeding of
HeLa cells, transfection with siRNA and the lipid reagent LF2000 (Invitrogen),
and preparation of samples for Western blotting were as described previously
(8). Cells were used for bacterial infections or stimulation with InlB or HGF
at approximately 48 h after transfection with siRNA. Control experiments
employing an 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bro-
mide (MTT) assay (28) or enumeration of CFU indicated that the control,
ARAP2-1, ARAP2-2, and Arf6 siRNAs did not affect viability of mammalian
cells or bacteria.
In some experiments (see Fig. 2 and 5), HeLa cells were first transfected with
siRNA and then approximately 24 h later transfected a second time with plasmid
DNA expressing various Flag-tagged proteins. In these experiments, transfec-
tions of siRNA and plasmid DNA with LF2000 were performed as described
previously (8).
Bacterial entry or association assays. Gentamicin protection assays to mea-
sure entry of Listeria strains (see Fig. 1B, 6B, and 7C) were performed by
infecting cells for 1 h in the absence of gentamicin and then incubating them in
DMEM with 20 g/ml gentamicin for 2 h as described previously (8, 37). In
experiments involving cell-permeative C3 toxin (see Fig. 7C), HeLa cells were
pretreated with 2 g/ml C3 in DMEM supplemented with 0.1% bovine serum
albumin (BSA) for 5 h prior to addition of bacteria. C3 toxin was left in contact
with cells during the 1-h infection period. Toxin was washed away just prior to the
2-h period involving gentamicin treatment. Cell association assays involving a
30-min infection period without subsequent gentamicin treatment were per-
formed as described previously (8).
Experiments measuring bacterial entry by a fluorescence microscopy-based
assay (see Fig. 1C, 2C, 4B [panel i], and 5A) were carried out essentially as
described previously (8, 38). Briefly, extracellular bacteria in fixed monolayers
were labeled by incubation with antiserum R11 at a dilution of 1:500 for 1 h,
followed by three washes and a second 1-h incubation with Cy5-conjugated
antibodies against rabbit IgG. As Texas Red-X-succinimidyl ester (TRXSE)-
labeled bacteria were used for infection, both extracellular and intracellular
bacteria were Texas Red positive. After labeling, intracellular bacteria were
negative for Cy5, whereas extracellular bacteria were Cy5 positive. Infected
mammalian cells were then permeabilized in phosphate-buffered saline (PBS)
containing 0.4% Triton X-100 for 5 min. In the case of HeLa cells expressing
tagged ARAP2 alleles (see Fig. 4B and 5A), permeabilized cells were labeled
with anti-Flag antibodies, followed by incubation with fluorescein isothiocyanate
(FITC)-conjugated secondary antibodies. This procedure typically resulted in
10% of the population subjected to transfection appearing brightly fluorescent
(Flag positive). Samples were mounted using Mowiol 4-88 (475904; Calbio-
chem). A Zeiss LSM 510 confocal microscope equipped with argon (488 nm),
helium-neon 1 (543 nm), and helium-neon 2 (633 nm) lasers was used for analysis
of bacterial entry. In the case of experiments for Fig. 2C, 4B (panel i), and 5A,
only cells that were positive for Flag-tagged protein expression were analyzed.
Images of five or six serial optical sections of 1 m in thickness were captured.
Optical sections started just above the host cell and ended below the cell. For
each section, images of Cy5, Texas Red, and FITC fluorescence were acquired.
Individual serial sections corresponding to Cy5 or Texas Red fluorescence were
superimposed so as to create a composite image containing all Cy5- or Texas
Red-positive bacteria throughout the host cell. The Cy5 and Texas Red images
(artificially colored in red and green, respectively) were then overlaid, resulting
in extracellular bacteria appearing yellow and intracellular bacteria red. Finally,
in experiments involving Flag-tagged ARAP2 alleles, the FITC fluorescent image
(artificially colored in blue) was superimposed on the Cy5/Texas Red overlay to
allow identification of bacteria associated with transfected cells. Typically, 50 to
100 intracellular bacteria were examined for the control condition in each ex-
periment. Control conditions for the various figures involved infection with
wild-type Listeria of the following cells: for Fig. 1C, cells treated with control
siRNA; for Fig. 2C, cells transfected with control siRNA and expressing Flag-
luciferase; for Fig. 4B, panel i, cells expressing Flag-tagged wild-type ARAP2
(ARAP2wt); and for Fig. 5A, cells transfected with control siRNA and express-
ing Flag-tagged wild-type ARAP2. The number of host cells analyzed under
control conditions was noted, and similar numbers of cells subjected to the other
experimental conditions were evaluated for Listeria entry.
Measurement of expression of Flag-tagged proteins by confocal microscopy.
Transfection of HeLa cells with plasmids expressing Flag-tagged luciferase,
ARAP2wt, ARAP2.R728K, or ARAP2.K1190P resulted in a subpopulation of
cells expressing the tagged transgene. Moreover, the proportions of cells express-
ing the various Flag-tagged proteins were not identical. For this reason, confocal
microscopy was used to quantify the level of expression of Flag-tagged proteins
in subpopulations of HeLa cells that were positive for Flag protein expression
(see Fig. 2B, 4B [panel ii], and 5B). In this way, expression levels in the sub-
population of cells that were analyzed for bacterial entry (see the description of
fluorescence-based measurement of bacterial entry above) were assessed. When
acquiring images by confocal microscopy, care was taken to ensure that identical
laser and gain settings were used when analyzing samples with different Flag-
tagged proteins. Quantification of pixel intensities in cells positive for Flag
staining was performed using Image J (version 1.43r) software. Briefly, the
“ROI” function was used to select individual cells, and the “measure” function
was employed to obtain average pixel intensities. Typically, average pixel inten-
sities of about 50 Flag-positive cells were quantified for each condition in each
experiment. The mean pixel intensities were then determined. Data in Fig. 2B,
4B (panel ii), and 5B are average pixel intensities  standard deviations (SD)
from three experiments.
Retrovirus-mediated expression of Arf6 alleles. Murine leukemia virus (MLV)
pseudotypes bearing the envelope protein of vesicular stomatitis virus (VSV)
were used to express enhanced GFP (EGFP) alone or EGFP-tagged wild-type or
Q67L alleles of human Arf6. These retroviral vectors are incapable of replica-
tion, as they lack the majority of the virus genome, but express the transgene
after integration into the cell chromosome. Transcription is driven by the viral
long terminal repeat (LTR) promoter/enhancer elements that flank the trans-
gene and is dependent solely on normal cellular transcription mechanisms.
Pseudotyped viruses were made essentially as described previously (20). Briefly,
293FT cells (Invitrogen) were transfected with plasmids encoding MLV Gag-Pol
and VSV G together with a plasmid encoding the EGFP-tagged construct
flanked by MLV LTRs and a 5 packaging sequence. The transfection was by
calcium phosphate precipitation. After 2 days, the culture supernatant was
passed through a 0.45-m filter to remove cell debris. The virus-containing
filtrate was then used immediately or frozen at 80C. The virus titer was
determined by infecting HEK293 cells and counting EGFP-expressing cells 2
days later. Virus was concentrated by centrifugation through a 20% sucrose
cushion and resuspension of the pellet in DMEM plus 10% FBS.
HeLa cells were infected with retroviruses, and the effect of retrovirus-medi-
ated expression of Arf6 alleles was determined as follows. First, 4  104 HeLa
cells per well were seeded in 24-well plates and grown for 24 h. EGFP,
Arf6wt-EGFP, or Arf6Q67L-EGFP transgenes were introduced into cells by
incubation with recombinant virus at a multiplicity of infection (MOI) of 5:1.
Cells were incubated with virus or control medium for 48 h before analysis of
protein expression or Listeria internalization. Fluorescence microscopy analysis
indicated that the retroviruses allow expression of EGFP, Arf6wt-EGFP, or
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Arf6Q67L-EGFP in 95 to 99% of HeLa cells. Before infection with bacterial
strains, retrovirus- or mock-infected cells were washed twice with DMEM. Gen-
tamicin protection assays were performed as described above. For Western
blotting, retrovirus-infected cells were solubilized in hot sample buffer, and
samples were migrated on 10% SDS-polyacrylamide gels and transferred to
polyvinylidene difluoride (PVDF) membranes. Membranes were probed with
commercially available anti-EGFP antibodies.
Western blotting and immunoprecipitation. Western blotting and detection
using enhanced chemiluminescence (ECL) or ECL Plus reagents (GE Health
Care) and film were performed as described previously (18, 37).
In experiments assessing tyrosine phosphorylation of Met (see Fig. 3), 8  104
HeLa cells per well were seeded in six-well plates. One six-well plate was used for
each stimulation condition. About 24 h later, cells were transfected with 30 nM
control or ARAP2-2 siRNA. Approximately 48 h after transfection, cells were
washed twice in PBS and serum starved in DMEM without FBS for 3 h.
Incubation of cells with InlB, HGF, or wild-type or inlB strains of Listeria;
preparation of cell lysates; immunoprecipitation of Met with antibody C-12; and
detection of tyrosine phosphorylation by Western blotting were all as described
previously (8, 37).
Real-time PCR analysis. HeLa cells (1.5 104) were seeded in wells of 24-well
plates. About 24 h later, cells were transfected with 10 nM control, ARAP2-1, or
ARAP2-2 siRNA as described previously (8). Approximately 48 h after trans-
fection, cells were washed twice in PBS and lysed, and a TaqMan Gene Expres-
sion Cells to Ct kit (Applied Biosystems) was used to prepare cDNA. Real-time
PCR was performed using an ABI7900 instrument and TaqMan gene expression
assays for ARAP2 (Hs00367391_m1; Applied Biosystems) and GAPDH (glyc-
eraldehyde-3-phosphate dehydrogenase) (Hs99999905_m1; Applied Biosystems)
as an endogenous control. Data were analyzed by the comparative threshold
cycle (CT method (25), normalizing CT values for ARAP2 expression to those
for GAPDH. Relative quantity (RQ) values were calculated by the formula
RQ  2CT.
Assessing effects of cell C3 toxin on the actin cytoskeleton. HeLa cells (2 
105) were seeded onto sterile 22- by 22-mm glass coverslips in six-well plates.
Cells were grown for approximately 2 days and then treated for 5 h with 2 g/ml
cell-permeative C3 toxin in DMEM supplemented with 0.1% BSA. After treat-
ment, cells were washed once in PBS, fixed in PBS with 3% paraformaldehyde,
and permeabilized by a 10-min incubation in PBS with 0.4% Triton X-100.
Samples were labeled for F-actin using phalloidin coupled to Texas Red (Mo-
lecular Probes). After mounting on coverslips using Mowiol, samples were ana-
lyzed using a Zeiss LSM confocal microscope with the helium-neon 1 (543 nm)
laser.
Measurement of internalization of InlB-coated beads and F-actin recruit-
ment. Carboxylate-modified latex beads 3.0 m in diameter (09850; Poly-
sciences) were used for coating with InlB protein, as described previously (8).
HeLa cells were incubated with InlB-coated beads for 10 min at 37°C with 5%
CO2, fixed, labeled, and analyzed by confocal microscopy as described previously
(8). The data in Fig. 8A are averages  SD from three experiments. In each
experiment, 100 to 300 intracellular beads were scored for control siRNA-treated
cells. The number of host cells analyzed was noted, and a similar number of
ARAP2-2 siRNA-treated cells was analyzed for entry of beads. The data in Fig.
8A, panel ii, are expressed as the percentage of total cell-associated beads that
were internalized. The data in Fig. 8A, panel i, are relative values obtained by
normalizing percent internalization values in Fig. 8A, panel ii, to values for
control siRNA-treated cells.
Recruitment of F-actin to adherent (extracellular) InlB-coated beads (see Fig.
8B and C) was assessed essentially as described previously (8). Images from serial
sections spaced 1 m apart were used to ensure that all cell-associated beads
were detected. Any beads that exhibited obvious recruitment of F-actin in “ring-
like” structures at the site of bead attachment (see bead 1 in Fig. 8B for an
example) were scored as positive. Beads that were not associated with rings
containing F-actin (see bead 2 in Fig. 8B) were considered to be negative. In the
case of cells treated with ARAP2-2 siRNA, InlB-coated beads were typically not
associated with cups containing F-actin and were scored as “negative.” More
rarely, weak accumulation of F-actin was observed, in which case beads were
scored as “positive.” Approximately 200 extracellular particles were scored for
F-actin recruitment for each condition in each experiment. Data showing the
percentage of cell-associated beads that were positive or negative for F-actin
recruitment (see Fig. 8C, panel i) are shown as the average  SD from three
experiments. In the case of beads that scored positive for recruitment, we also
quantified enrichment of F-actin around the bead relative to F-actin throughout
the cell (see Fig. 8C, panel ii). The thresholding function of Image J (version
1.43r) software was used to select F-actin rings surrounding a bead. The average
pixel intensity of F-actin around the bead was then determined. This average
pixel intensity surrounding the bead was normalized to the average F-actin pixel
intensity throughout the cell. The corresponding ratio was termed the “F-actin
enrichment factor,” where a value greater than 1.0 indicates enrichment of
F-actin around the bead compared to in the entire cell. The data in Fig. 8C, panel
ii, represent averages  SD from three experiments. In each of these experi-
ments, 30 to 50 beads were used under each condition for calculation of F-actin
enrichment values.
Statistical analysis. Statistical analysis was performed using InStat (version
2.2; GraphPad Software). When comparing data sets from two conditions, a
Student t test was used. When comparing data from three or more conditions,
analysis of variance (ANOVA) was performed. The Tukey-Kramer test was used
as a posttest. A P value of 0.05 or lower was considered significant.
RESULTS
The human GAP ARAP2 is needed for InlB-dependent entry
of Listeria. Host type IA PI 3-kinase (here abbreviated as
p85-p110) plays a critical role in entry of Listeria downstream
of the Met receptor (8, 16, 17, 18, 37). In order to better
understand the molecular mechanism by which p85-p110 pro-
motes bacterial entry, we sought to identify human proteins
that act downstream of p85-p110 in this process. p85-p110
produces PI(3,4)P2 and PI(3,4,5)P3, two phosphoinositides
that bind to a multitude of signaling proteins and control a
variety of biological events in mammalian cells (4, 11, 24). We
performed a literature search to identify mammalian proteins
reported to be regulated by p85-p110. A list of approximately
60 human proteins was compiled (S. Jiwani and K. Ireton,
unpublished data). Most of these PI 3-kinase-regulated pro-
teins interact directly with PI(3,4)P2 or PI(3,4,5)P3 or with the
PI 3-kinase subunit p85 or p110. In a few cases, host proteins
that are indirectly regulated by p85-p110 were included. The
list of p85-p110-regulated proteins was used to construct an
siRNA library, and this library was screened for effects on host
target gene expression and entry of Listeria. The siRNA-based
screen will be the subject of a future publication. Here, we
describe the role of one of the human proteins identified from
the siRNA screen in InlB-mediated entry of Listeria. This pro-
tein is the GTPase-activating protein (GAP) ARAP2 (27, 42).
ARAP2 contains pleckstrin homology (PH) domains (24, 34)
that bind to PI(3,4,5)P3, resulting in upregulation of the GAP
activity of ARAP2 (42). In this way, p85-p110 regulates the
enzymatic activity of ARAP2.
We found that siRNA-mediated depletion of ARAP2 caused a
marked inhibition of entry of Listeria into HeLa cells (Fig. 1).
Inhibition of entry was observed using two different assays,
involving gentamicin protection (Fig. 1B, panel i) or fluores-
cence microscopy (Fig. 1C). Two lines of evidence indicated
that the inhibitory effect of ARAP2 siRNA on Listeria inter-
nalization was genuine and not due to an “off-target” effect of
the siRNA. First, two different siRNA molecules targeting
distinct regions in ARAP2 mRNA caused depletion of ARAP2
and impairment of Listeria uptake (Fig. 1A and B). Inhibition
of ARAP2 gene expression was confirmed by both Western
blotting (Fig. 1A) and real-time PCR analysis. The latter
approach indicated that ARAP2-1 and ARAP2-2 siRNAs
reduced ARAP2 mRNA to 16 and 10%, respectively, of control
levels. The second line of evidence that excluded the possibility
of an off-target effect involved a “rescue” experiment. The
defect in bacterial entry normally caused by an siRNA target-
ing the 3 untranslated region (UTR) of ARAP2 mRNA was
complemented by expression of an ARAP2 cDNA lacking the
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3 UTR (Fig. 2). Thus, by expressing a resistant ARAP2
cDNA, it was possible to restore normal internalization of
Listeria in the presence of the ARAP2-1 siRNA.
Importantly, the ability of Listeria to associate with HeLa
cells was unaffected by ARAP2 depletion (Fig. 1B, panel ii).
This finding suggests that ARAP2 is not needed for binding of
bacteria to host cells but rather affects postbinding events. In
agreement with this idea, ARAP2 depletion did not affect the
ability of InlB protein or bacteria to induce activation (tyrosine
phosphorylation) of the Met receptor (Fig. 3). We also tested
the ability of the cellular ligand of Met, hepatocyte growth
factor (HGF) (12), to stimulate phosphorylation of the recep-
tor. Similar to the results observed with InlB and bacteria,
HGF-induced phosphorylation was unaffected by ARAP2 de-
pletion (Fig. 3A). The results in Fig. 3 indicate that ARAP2
controls entry of Listeria by acting downstream of Met.
The ArfGAP and RhoGAP domains in ARAP2 play im-
portant roles in Listeria entry. ARAP2 has several functional
domains, including an ArfGAP domain that inactivates the
GTPase Arf6 and a domain that associates with the activated
form of the GTPase RhoA (Fig. 4A) (27, 33, 42). Interestingly,
the ArfGAP domain is activated by PI(3,4,5)P3 (42), suggesting
that type IA PI 3-kinase enhances ARAP2-mediated inhibition
of Arf6. The domain in ARAP2 that binds RhoA-GTP has
sequence similarity with GAP domains for Rho GTPases
and hence has been termed a “RhoGAP” domain (27, 33,
42). However, this domain in ARAP2 is different from true
RhoGAP domains in that it lacks a key catalytic arginine res-
idue and is consequently unable to stimulate GTP hydrolysis
(27, 42). Since the RhoGAP domain functions as a Rho-inter-
acting module rather than as a GAP, we here refer to this
region as a “RhoA binding” (RB) domain.
In order to test the roles of the ARAP2 ArfGAP and RB
domains in internalization of Listeria, we used mutant alleles
containing single amino acid substitutions that inactivate these
domains (Fig. 4A). The ARAP2.R728K allele contains a mu-
tation that abolishes the ability of ARAP2 to stimulate GTP
hydrolysis on Arf6 (42). The K1190P allele of ARAP2 is de-
fective for interaction with RhoA-GTP. We transiently ex-
pressed Flag-tagged wild-type ARAP2, ARAP2.R728K, or
ARAP2.K1190P in HeLa cells and measured bacterial entry
using a previously described fluorescence microscopy-based
approach (see Materials and Methods) (38). Importantly, com-
pared to tagged wild-type ARAP2, the ARAP2.R728K or
ARAP2.K1190P allele inhibited internalization of Listeria by
60% or 75%, respectively (Fig. 4B, panel i). Quantitative
confocal microscopy (see Materials and Methods) indicated
that Flag-tagged wild-type, R728K, and K1190P ARAP2 al-
leles were expressed at similar levels (Fig. 4B, panel ii). Taken
together, the results in Fig. 4 indicate that both the ArfGAP
FIG. 1. InlB-mediated entry of Listeria requires the host GAP ARAP2. (A) Effect of siRNA molecules on ARAP2 expression. HeLa cells were
left untreated () or transfected with a control siRNA or either of two siRNA molecules targeting ARAP2 (ARAP2-1 or ARAP2-2). At about
48 h posttransfection, cells were solubilized for measurement of ARAP2 expression by Western blotting. (B) Effect of siRNAs targeting ARAP2
on entry or association of Listeria. Transfected HeLa cells were infected with wild-type (Wt) Listeria or an isogenic mutant strain with inlB deleted
(inlB). Panel i, bacterial entry was assessed using a gentamicin protection assay (37). Panel ii, association of bacteria with host cells was measured
as described previously (8). Values are averages  standard errors of the means (SEM) from three or four experiments. *, P 	 0.01 compared
to the no-siRNA control (). **, P 	 0.001. (C) Effect of ARAP2 depletion on internalization of Listeria, as determined by a fluorescence
microscopy-based assay (38). Values are averages  standard deviations (SD) from three experiments. *, P 	 0.01 compared to control siRNA
conditions. **, P 	 0.001.
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and RB domains in ARAP2 have important functions in entry
of Listeria.
The ArfGAP domain in ARAP2 promotes Listeria entry by
inactivating the GTPase Arf6. The bulk of evidence supports
the idea that the in vivo substrate of the ARAP2 ArfGAP
domain is the GTPase Arf6 (42). However, in vitro, both Arf6
and the related GTPase Arf5 can be inactivated by the ARAP2
ArfGAP domain (42). In order to determine if the ArfGAP
activity in ARAP2 controls Listeria entry by inhibiting Arf6, we
investigated the effect of RNA interference (RNAi)-mediated
depletion of Arf6 in cells expressing the ARAP2.R728K allele.
If the ArfGAP domain affects bacterial entry through Arf6,
then depletion of Arf6 would be expected to restore normal
entry to cells expressing ARAP2.R728K. Indeed, we found
that RNAi-mediated knockdown of Arf6 suppressed the
defect in Listeria internalization normally caused by the
ARAP2.R728K allele (Fig. 5). Importantly, depletion of Arf6
did not affect bacterial entry in cells expressing tagged wild-
type or K1190P ARAP2. Collectively, the results in Fig. 5
indicate that the ArfGAP domain in ARAP2 stimulates uptake
of Listeria by inactivating host Arf6.
The results in Fig. 5 imply that activated (GTP-bound) Arf6
antagonizes Listeria entry. In order to further investigate this
idea, we tested the effect of expression of a constitutively ac-
tivated form of Arf6 (Arf6Q67L) on bacterial internalization.
The Arf6Q67L protein is locked in the GTP-bound state be-
cause of a defect in GTP hydrolysis (9, 22). Hence, GAPs, such
as ARAP2, cannot help inactivate the Arf6Q67L protein. In
support of the data in Fig. 5, expression of the Arf6Q67L allele
caused a marked inhibition in uptake of Listeria into HeLa
cells (Fig. 6).
The RB domain in ARAP2 controls entry of Listeria inde-
pendently of host Rho proteins. The RB (formerly RhoGAP)
domain in ARAP2 is known to interact with GTP-bound RhoA
(42). Given the importance of the RB domain in entry of
Listeria (Fig. 4B), we investigated the role of host Rho proteins
(19) in this process. HeLa cells were treated with C3, a toxin
known to inactivate RhoA and other Rho proteins (5, 40). Rho
protein activity was monitored by assessing the integrity of
stress fibers, which are F-actin structures regulated by RhoA
and related GTPases. Treatment of HeLa cells with C3 toxin (2
FIG. 2. Restoration of ARAP2 expression allows normal entry of
Listeria in the presence of ARAP2 siRNA. (A) Expression of an
ARAP2 cDNA that is resistant to siRNA-mediated depletion. HeLa
cells were transfected with either control (C) siRNA or ARAP2-1
(A2-1) siRNA, which targets the 3 untranslated region (UTR) present
in endogenous ARAP2 mRNA. Cells were transfected again with
plasmids expressing either Flag-tagged luciferase (L) or ARAP2
(AR2) encoded by a cDNA that lacks the 3 UTR. At about 24 h after
plasmid DNA transfection, ARAP2 expression was evaluated by West-
ern blotting. Note that ectopic expression of ARAP2 lacking the 3
UTR (AR2) restored normal ARAP2 levels to cells treated with
ARAP2-1 (A2-1) siRNA. (B) Levels of Flag-tagged luciferase or
ARAP2 expression. Confocal microscopy was used to measure relative
expression of tagged luciferase or ARAP2 proteins in transfected
HeLa cells. P  0.19 (not significant). (C) Restoration of bacterial
entry in cells expressing ARAP2 resistant to siRNA-mediated deple-
tion. A fluorescence microscopy-based assay (38) was used to measure
entry of Listeria in cells transfected with siRNAs and expressing Flag-
tagged luciferase or ARAP2. Values are averages  SD from three
experiments. *, P 	 0.001 compared to the luciferase (L) plus control
siRNA (C) condition.
FIG. 3. ARAP2 is dispensable for activation of the Met receptor.
HeLa cells were transfected with 30 nM control or ARAP2-2 (A2-2)
siRNA for 48 h. Cells were then treated with either InlB protein (4.5
nM) or HGF (1 nM) for 1 min (A) or infected with wild-type (wt) or
inlB (B) strains of Listeria for 5 min (B). Top panels, tyrosine
phosphorylation of Met was evaluated by Western blotting of anti-Met
immunoprecipitates (IP) (8, 37). Middle panels, depletion of ARAP2
was assessed by Western blotting of total cell lysates. Bottom panels,
equivalent loading of total cell lysates was confirmed by probing
stripped membranes with antitubulin antibodies. The results are rep-
resentative of two experiments.
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mg/liter for 5 h) resulted in a marked disappearance of stress
fibers (Fig. 7A), indicating strong inhibition of Rho proteins.
Despite the severe inhibitory effect of C3, entry of Listeria was
not impaired by toxin treatment (Fig. 7B). In fact, bacterial
uptake was enhanced by about 2-fold, suggesting an antago-
nistic role for Rho proteins in entry. Taken together, the re-
sults in Fig. 7 indicate that InlB-mediated entry of Listeria does
not require activated host Rho proteins. These findings suggest
that the RB domain in ARAP2 likely promotes internalization
of Listeria through a mechanism independent of Rho proteins.
ARAP2 is needed for F-actin cytoskeletal changes during
InlB-mediated entry. InlB-mediated entry of Listeria requires
rearrangements in the F-actin cytoskeleton (8, 16, 17, 29).
These cytoskeletal changes are thought to elicit host cell sur-
face changes that drive Listeria engulfment. Importantly, type
IA PI 3-kinase (p85-p110) plays a critical role in F-actin rear-
rangements during InlB-mediated uptake (8).
Given that ARAP2 ArfGAP activity is stimulated by lipid
products of p85-p110 (42), we wondered if ARAP2 is needed
for cytoskeletal changes during InlB-mediated internalization.
In order to investigate this possibility, we used 3-m latex
beads coated with InlB protein. Our previous work indicated
that these InlB-coated beads are internalized by HeLa cells
through a mechanism that is indistinguishable from that uti-
lized by Listeria (8). Moreover, F-actin cytoskeletal changes
are more readily detected with InlB-coated beads than with
bacteria, perhaps because of a greater amount of InlB on the
surface of the beads (8). Importantly, we found that RNAi-
mediated depletion of ARAP2 caused a marked inhibition of
entry of InlB-coated beads (Fig. 8A) and of accompanying
F-actin rearrangements (Fig. 8B and C). In HeLa cells treated
with control siRNA and incubated with InlB-coated beads for
2.5 min, 45% of beads were encircled by structures enriched
in F-actin (Fig. 8B and C, panel i). Quantitative confocal mi-
croscopy analysis indicated that the degree of F-actin enrich-
ment around beads, compared to the average F-actin distribu-
tion through the entire cell (see Materials and Methods), was
roughly 4-fold (Fig. 8C, panel ii). We note that, even under
control conditions, not every HeLa cell displayed obvious F-
actin accumulation (Fig. 8B, panel i). On average, 50% of
cells treated with control siRNA recruited F-actin near adher-
ent beads. While the reason for this heterogeneity in F-actin
accumulation is not known, it is consistent with the fact that
40 or 50% of HeLa cells internalized beads or Listeria,
FIG. 4. The ArfGAP and Rho binding domains of ARAP2 pro-
mote entry of Listeria. (A) Domains present in ARAP2 and locations
of R728K and K1190P mutations. SAM, sterile 
 motif; PH, pleckstrin
homology domain; ArfGAP, Arf GTPase-activating protein; A, ankyrin
repeat; RB, Rho binding domain; RA, Ras-associating domain. Top di-
agram, wild-type (wt) ARAP2. Bottom two diagrams, ARAP2 alleles
R728K and K1190P, containing single amino acid substitutions that inac-
tivate the ArfGAP and RhoA binding domains, respectively. (B) Effect of
mutations in the ArfGAP or Rho binding domain on bacterial internal-
ization. HeLa cells were transfected with plasmids expressing Flag-tagged
wild-type (wt) ARAP2 or ARAP2 alleles containing the R728K or
K1190 mutation. Panel i, at approximately 24 h posttransfection, entry
of Listeria was assessed using a fluorescence microscopy-based assay
(38). Data are averages  SD from four experiments. *, P 	 0.001
compared to the ARAP2wt control. Panel ii, expression of the Flag-
tagged ARAP2 alleles was measured using confocal microscopy (see
Materials and Methods). P  0.32 (not significant).
FIG. 5. ARAP2 promotes entry of Listeria in part by inactivating
host Arf6 GTPase. (A) Depletion of Arf6 restores bacterial internal-
ization to cells expressing ARAP2.R278K. HeLa cells were transfected
with control or Arf6 (A6) siRNA and then with plasmids expressing
Flag-tagged wild-type (WT), R728K, or K1190P alleles of ARAP2.
Entry of Listeria was measured using a fluorescence microscopy-based
assay (38) (see Materials and Methods). Data are averages  SD from
three experiments. *, P 	 0.001 compared to the ARAP2wt plus
control siRNA condition. (B) Expression of ARAP2 alleles. Expres-
sion of Flag-tagged ARAP2 proteins was measured using confocal
microscopy (see Materials and Methods). P  0.59 (not significant).
(C) Depletion of Arf6. siRNA-mediated depletion of Arf6 was con-
firmed by Western blotting.
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respectively. Importantly, in cells treated with ARAP2 siRNA,
only 11% of cell-associated beads displayed obvious recruit-
ment of F-actin (Fig. 8B and C, panel i). Of these beads that
were encircled by F-actin, the intensity of actin was diminished
relative to that in control siRNA-treated cells (Fig. 8C, panel
ii). Collectively, the data in Fig. 8 indicate that host ARAP2
plays an important role in F-actin rearrangements during InlB-
mediated entry.
DISCUSSION
In this work, we show that the human GTPase-activating
protein (GAP) ARAP2 plays a critical role in InlB-mediated
entry of Listeria. ARAP2 is a large, multidomain protein that
controls bacterial uptake through at least two distinct pathways
(Fig. 9). The ArfGAP domain in ARAP2 promotes internal-
ization of Listeria by inactivating the host GTPase Arf6. The
ARAP2 RhoA binding (RB) domain likely contributes to entry
by binding an unidentified host ligand. Importantly, ARAP2 is
needed for actin cytoskeletal rearrangements that drive InlB-
mediated internalization. Altogether, our findings have iden-
tified ARAP2 as a crucial host factor that mediates F-actin
changes and pathogen engulfment downstream of the Met
receptor tyrosine kinase.
ARAP2 is probably coupled to the Met receptor through the
host type IA PI 3-kinase p85-p110 (Fig. 9). Binding of Listeria
or InlB protein to Met results in activation of p85-p110 and
accumulation of its lipid product phosphatidylinositol 3,4,5-
trisphosphate [PI(3,4,5)P3] (8, 17, 18). Importantly, PI(3,4,5)P3
stimulates the ArfGAP activity in ARAP2 (42), indicating that
ARAP2 is regulated by p85-p110. The sites of binding of
PI(3,4,5)P3 are predicted to be the first, fifth, and perhaps third
pleckstrin homology (PH) domains in ARAP2 (27, 42). In
combination with previous findings on ARAP2 (27, 42), our
work indicates that this GAP is one of the likely downstream
targets of p85-p110 involved in Listeria entry.
How does ARAP2 contribute to internalization of Listeria?
Our work indicates that both the ArfGAP and RhoA binding
(RB) domains of ARAP2 play important roles in bacterial
entry. Although the RB domain in ARAP2 is known to control
actin stress fiber formation by interacting with the GTPase
RhoA (42), our results indicate that Rho proteins were dis-
pensable for Listeria uptake. Treatment of host cells with C3
exoenzyme, a toxin that inactivates RhoA and other Rho pro-
teins (5, 40), failed to impair bacterial entry. This finding with
C3 is in agreement with previous results indicating that expres-
sion of a dominant negative allele of RhoA did not interfere
with InlB-mediated bacterial entry (2). Since Listeria internal-
ization does not require host Rho activity, it is likely that the
RB domain in ARAP2 acts by binding a cellular factor apart
from Rho proteins. In future work, it will be interesting to
identify novel ligands of the RB domain. Finding such ligands
will help us to understand how ARAP2 controls entry of Lis-
teria and may also provide new information on the normal
cellular functions of ARAP2.
Our genetic data indicated that the ArfGAP domain in
ARAP2 stimulates uptake of Listeria by antagonizing the hu-
man GTPase Arf6. In cells expressing normal levels of Arf6,
ectopic expression of ARAP2 mutated in its ArfGAP domain
(ARAP2.R728K) inhibited bacterial entry. Importantly, this
impairment in entry was suppressed by RNAi-mediated de-
pletion of Arf6. In addition, a constitutively activated allele
of Arf6 (Arf6Q67L) blocked internalization of Listeria. Col-
lectively, these genetic data indicate that in the absence of
ARAP2, Arf6-GTP inhibits internalization of Listeria. In nor-
mal situations where ARAP2 is present, this GAP relieves
FIG. 6. Constitutively activated Arf6 blocks internalization of Lis-
teria. HeLa cells were infected with retrovirus expressing either EGFP
alone, EGFP-tagged wild-type (wt) Arf6, or tagged constitutively ac-
tivated (Q67L) Arf6. At about 24 h after addition of retrovirus, cells
were solubilized for assessment of EGFP protein expression by West-
ern blotting. (B) Cells were infected with wild-type or inlB strains of
Listeria, and entry was measured by a gentamicin protection assay (37).
Data are averages  SD from three experiments. *, P 	 0.001 com-
pared to the EGFP control.
FIG. 7. Host Rho activity is dispensable for InlB-mediated entry of
Listeria. (A) Disruption of F-actin stress fibers by C3 toxin. HeLa cells
left untreated () or treated with 2 g/ml cell-permeative C3 for 5 h
() were fixed and labeled with phalloidin coupled to Texas Red in
order to detect the F-actin cytoskeleton. Untreated cells exhibit pro-
nounced stress fibers, whereas stress fibers are largely absent in cells
treated with C3. Scale bars, 10 m. (B). Lack of inhibition of bacterial
internalization by C3 exoenzyme treatment. HeLa cells pretreated ()
or not () with cell-permeative C3 toxin were infected with wild-type
(Wt) or inlB strains of Listeria, and entry was measured using gen-
tamicin protection assay (37). Despite the strong inhibitory effect of C3
on the F-actin cytoskeleton (A), the toxin did not impair entry of
Listeria. Data are averages  SD from three experiments. *, P 	 0.01
compared to untreated cells infected with wild-type Listeria.
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Arf6-GTP-mediated inhibition. Based on our results, we
postulate that ARAP2 restrains accumulation of Arf6-GTP,
which would otherwise interfere with entry of Listeria (Fig.
9). A prediction from these genetic studies is that Arf6-GTP
amounts would increase in HeLa cells depleted of ARAP2.
Using a previously described coprecipitation approach (31,
35), we made several unsuccessful attempts to measure endog-
enous Arf6-GTP in control and ARAP2-depleted cells. The
inability to detect Arf6-GTP could reflect a low abundance of
activated Arf6 in HeLa cells or could be due to limited sensi-
tivity of the anti-Arf6 antibodies used in Western blotting.
Regardless of technical issues encountered in the biochemical
experiments, our genetic data are consistent with the mecha-
nism of action of ARAP2 and Arf6 depicted in Fig. 9.
FIG. 8. ARAP2 is needed for cytoskeletal rearrangements during InlB-mediated entry. (A) Inhibition of internalization of InlB-coated beads
by siRNA-mediated depletion of ARAP2. HeLa cells treated with control or ARAP2-2 siRNA were incubated with InlB-coated beads for 10 min.
Entry of beads was measured using a fluorescence microscopy-based assay (8). Panel i, entry expressed as internalization relative to that in control
siRNA-treated cells. Panel ii, entry expressed as absolute values (percentage of beads internalized). Values are averages  SD from three
experiments. P  0.0054. (B) Inhibition of F-actin cytoskeletal changes by depletion of ARAP2. HeLa cells treated with control or ARAP2-2
siRNA were incubated with InlB-coated beads for 2.5 min, followed by fixation and labeling for beads (red) or F-actin (green). Panel i, images of
several cells showing labeling of both F-actin and beads or F-actin only. Arrows indicate beads encircled by F-actin. Arrowheads show cell-
associated beads that do not display obvious F-actin recruitment. Scale bars indicate 5 m. Panel ii, enlarged images of selected beads (numbered
1 to 4) and associated F-actin indicated in panel i. In the case of beads that recruit F-actin, recruitment in control siRNA-treated cells (bead 1)
is typically more intense than that in cells depleted for ARAP2 (bead 3). (C) Quantification of the effect of ARAP2 depletion on cytoskeletal
changes. Panel i, confocal microscopy was used to quantify the percentage of beads associated with F-actin. For examples of beads recruiting or
not recruiting F-actin, see beads 1 to 4 in panel ii of panel B. HeLa cells treated with ARAP2-2 siRNA had fewer actin-associated beads than
control siRNA-treated cells. P  0.0007. Panel ii, confocal microscopy was used to quantify the degree of F-actin enrichment around beads in cells
treated with control or ARAP2-2 siRNA. This analysis included only beads that displayed obvious association with F-actin. For examples, see beads
1 and 3 in panel ii of panel B. Beads bound to cells treated with ARAP2-2 siRNA displayed reduced enrichment of F-actin compared to beads
adhering to control siRNA-treated cells. P  0.0002. The data in both panel i and ii are averages  SD from three experiments.
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How unrestrained accumulation of Arf6-GTP might inter-
fere with entry of Listeria is not known. One possibility is that
deregulation of Arf6 through depletion of ARAP2 elicits mem-
brane trafficking events that sequester one or more host factors
needed for internalization of Listeria. Previous studies indicate
that the Arf6Q67L constitutively activated mutant causes the
intracellular accumulation of cholesterol and phosphatidylino-
sitol 4,5-bisphosphate [PI(4,5)P2] in enlarged vacuoles (3, 30).
Interestingly, cholesterol-rich lipid rafts at the plasma mem-
brane are needed for InlB-mediated uptake of Listeria (36).
PI(4,5)P2 plays a critical role in actin polymerization in mam-
malian cells and also is required for endocytosis and phagocy-
tosis in macrophages (34). Although the role of PI(4,5)P2 in
uptake of Listeria has yet to be addressed, an important func-
tion for this phosphoinositide in bacterial entry seems likely. In
future studies, it will be interesting to investigate if ARAP2
controls Listeria entry by maintaining proper levels of choles-
terol and PI(4,5)P2 at the plasma membrane.
Interestingly, in addition to affecting entry of Listeria, Arf6
regulates internalization of several other bacterial, viral, and
protozoan pathogens, including Yersinia (41), Chlamydia (1),
baculovirus (21), coxsackievirus A9 (15), Leishmania (26), and
Toxoplasma (6). However, in the cases of these other microbial
pathogens, Arf6 positively contributes to entry into host cells.
Notably, RNAi-mediated silencing of Arf6 and/or expression
of Arf6 interfering mutants impairs entry of these pathogens.
In contrast to the situation with these microbes, our findings
with Listeria indicate a negative role for Arf6 that must be
overcome by ARAP2 in order to allow efficient bacterial entry.
The collective data on Arf6 suggest that the GTPase can use
distinct mechanisms to control internalization of different mi-
crobial pathogens. The specific mechanism employed by Arf6
may depend on the cellular surface receptor recognized by the
pathogen.
In summary, our studies have uncovered a critical role for
the human signaling protein ARAP2 in InlB-dependent entry
of Listeria. Future work with Listeria has the potential to iden-
tify novel ligands of ARAP2 domains, such as the Rho binding
(RB) domain, and may also contribute to a better understand-
ing of the cellular consequences of unrestrained activation of
Arf6 GTPase. Finally, our findings that ARAP2 controls bac-
terial entry mediated by the Met receptor raise the possibility
that ARAP2 might also contribute to some of the normal
biological functions of Met. Such functions controlled by Met
and its cellular ligand HGF include mammalian cell growth,
motility, and morphogenesis (12).
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